DocuSign (DOCU) stock tanks despite healthy Q1 results, with billings missing guidance and lowered full-year outlook. Hold rating reaffirmed.
Latest Ratings for DOCU
DateFirmActionFromTo Mar 2022Piper SandlerMaintainsNeutral Mar 2022Wolfe ResearchMaintainsPeer Perform Mar 2022Wells FargoMaintainsEqual-Weight